SG11201804670PA - Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds - Google Patents
Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compoundsInfo
- Publication number
- SG11201804670PA SG11201804670PA SG11201804670PA SG11201804670PA SG11201804670PA SG 11201804670P A SG11201804670P A SG 11201804670PA SG 11201804670P A SG11201804670P A SG 11201804670PA SG 11201804670P A SG11201804670P A SG 11201804670PA SG 11201804670P A SG11201804670P A SG 11201804670PA
- Authority
- SG
- Singapore
- Prior art keywords
- sfl
- lioz
- alp
- tof
- uopdaiatd
- Prior art date
Links
- IKLWZGVCUZDMEL-UHFFFAOYSA-N 6-phenyl-5,6-dihydrobenzo[f]isoquinolin-2-amine Chemical class C1=NC(N)=CC(C2=CC=CC=C22)=C1CC2C1=CC=CC=C1 IKLWZGVCUZDMEL-UHFFFAOYSA-N 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
- 241000728904 Iais Species 0.000 abstract 2
- 241000816088 Papia Species 0.000 abstract 1
- 241000364051 Pima Species 0.000 abstract 1
- 238000007735 ion beam assisted deposition Methods 0.000 abstract 1
- 230000036651 mood Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/84—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562268747P | 2015-12-17 | 2015-12-17 | |
PCT/US2016/067164 WO2017106642A1 (en) | 2015-12-17 | 2016-12-16 | Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201804670PA true SG11201804670PA (en) | 2018-07-30 |
Family
ID=59057612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201804670PA SG11201804670PA (en) | 2015-12-17 | 2016-12-16 | Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds |
Country Status (19)
Country | Link |
---|---|
US (3) | US9981921B2 (zh) |
EP (2) | EP3390369B1 (zh) |
JP (2) | JP2018537499A (zh) |
KR (1) | KR20180086508A (zh) |
CN (1) | CN108368061A (zh) |
AU (2) | AU2016369523B2 (zh) |
BR (1) | BR112018012095A2 (zh) |
CA (1) | CA3006081A1 (zh) |
EA (2) | EA036295B1 (zh) |
ES (1) | ES2935818T3 (zh) |
HK (1) | HK1256825A1 (zh) |
IL (1) | IL259556B2 (zh) |
MX (2) | MX2018007414A (zh) |
NZ (1) | NZ742695A (zh) |
PH (2) | PH12018501246A1 (zh) |
SA (1) | SA518391805B1 (zh) |
SG (1) | SG11201804670PA (zh) |
TW (2) | TWI771280B (zh) |
WO (1) | WO2017106642A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017106642A1 (en) | 2015-12-17 | 2017-06-22 | Arqule, Inc. | Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds |
TWI748972B (zh) | 2015-12-17 | 2021-12-11 | 美商亞闊股份有限公司 | 製備經取代5,6-二氫-6-苯基苯并[f]異喹啉-2-胺之方法 |
WO2022053708A1 (en) | 2020-09-14 | 2022-03-17 | Basilea Pharmaceutica International AG | Pharmaceutical combinations for use in the treatment of gastric adenocarcinoma |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
AU5330698A (en) * | 1996-12-23 | 1998-07-17 | Celltech Therapeutics Limited | Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors |
GB9713087D0 (en) * | 1997-06-20 | 1997-08-27 | Celltech Therapeutics Ltd | Chemical compounds |
JP4037898B2 (ja) * | 2003-06-18 | 2008-01-23 | テバ ファーマシューティカル インダストリーズ リミティド | フルバスタチンナトリウム結晶形xiv、lxxiii、lxxix、lxxx及びxxxvii型、それらの調製方法、それらを含有する組成物及びそれらの使用方法 |
CN110551105B (zh) * | 2006-12-29 | 2022-10-18 | 里格尔制药公司 | 用作axl抑制剂的取代三唑 |
EP2379506B1 (en) * | 2008-12-30 | 2015-09-02 | ArQule, Inc. | Substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds |
EA024026B1 (ru) * | 2010-11-25 | 2016-08-31 | Рациофарм Гмбх | Новые соли и полиморфные формы афатиниба |
WO2012177852A1 (en) | 2011-06-24 | 2012-12-27 | Arqule, Inc | Substituted imidazopyridinyl compounds |
US9802954B2 (en) * | 2011-08-24 | 2017-10-31 | Boehringer Ingelheim International Gmbh | Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma |
JP2014530805A (ja) * | 2011-09-30 | 2014-11-20 | スンシネ ルアケ プハルマ カンパニー リミテッド | アジルサルタンの結晶形並びにその製造及び使用 |
WO2017106642A1 (en) * | 2015-12-17 | 2017-06-22 | Arqule, Inc. | Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds |
TWI748972B (zh) * | 2015-12-17 | 2021-12-11 | 美商亞闊股份有限公司 | 製備經取代5,6-二氫-6-苯基苯并[f]異喹啉-2-胺之方法 |
US9847831B2 (en) | 2016-04-08 | 2017-12-19 | Ciena Corporation | Dual wavelenth optical time domain reflectometer systems and methods embedded in a WDM system |
-
2016
- 2016-12-16 WO PCT/US2016/067164 patent/WO2017106642A1/en active Application Filing
- 2016-12-16 TW TW105141873A patent/TWI771280B/zh active
- 2016-12-16 IL IL259556A patent/IL259556B2/en unknown
- 2016-12-16 TW TW111124239A patent/TWI796250B/zh active
- 2016-12-16 JP JP2018531388A patent/JP2018537499A/ja active Pending
- 2016-12-16 CA CA3006081A patent/CA3006081A1/en active Pending
- 2016-12-16 EA EA201891430A patent/EA036295B1/ru unknown
- 2016-12-16 MX MX2018007414A patent/MX2018007414A/es unknown
- 2016-12-16 NZ NZ742695A patent/NZ742695A/en unknown
- 2016-12-16 KR KR1020187020340A patent/KR20180086508A/ko not_active Application Discontinuation
- 2016-12-16 EA EA202091691A patent/EA202091691A1/ru unknown
- 2016-12-16 MX MX2021000432A patent/MX2021000432A/es unknown
- 2016-12-16 EP EP16876769.7A patent/EP3390369B1/en active Active
- 2016-12-16 SG SG11201804670PA patent/SG11201804670PA/en unknown
- 2016-12-16 ES ES16876769T patent/ES2935818T3/es active Active
- 2016-12-16 CN CN201680073181.8A patent/CN108368061A/zh active Pending
- 2016-12-16 EP EP21216052.7A patent/EP4019499A1/en active Pending
- 2016-12-16 AU AU2016369523A patent/AU2016369523B2/en not_active Ceased
- 2016-12-16 BR BR112018012095A patent/BR112018012095A2/pt not_active Application Discontinuation
- 2016-12-16 US US15/381,414 patent/US9981921B2/en active Active
-
2018
- 2018-04-30 US US15/966,091 patent/US10227311B2/en active Active
- 2018-06-13 PH PH12018501246A patent/PH12018501246A1/en unknown
- 2018-06-13 SA SA518391805A patent/SA518391805B1/ar unknown
- 2018-12-12 HK HK18115910.5A patent/HK1256825A1/zh unknown
-
2019
- 2019-01-30 US US16/261,744 patent/US10717710B2/en active Active
-
2020
- 2020-09-14 PH PH12020551465A patent/PH12020551465A1/en unknown
-
2021
- 2021-11-26 JP JP2021191696A patent/JP2022031797A/ja active Pending
-
2022
- 2022-03-21 AU AU2022201947A patent/AU2022201947B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201804670PA (en) | Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds | |
HK1087133A1 (en) | Method for producing aqueous dispersions | |
JP2016504275A5 (zh) | ||
EP1790665A4 (en) | PROCESS FOR PREPARING A WATER-SOLUBLE HYALURONIC ACID MODIFICATION | |
WO2014176606A8 (en) | Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells | |
EP1959208A3 (de) | Luftverteiler, Luftverteiler-System sowie Luftverteilungs-System | |
EP2106197A3 (en) | Apparatus, methods and systems for providing lighting and communication | |
WO2011065800A3 (ko) | 피리미딘 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물 | |
WO2007006403A3 (en) | Biomaterials in the form of fibres for use as medical devices in the treatment of wounds, and their production process | |
EP4096805A4 (en) | GRAVITY FED FILTER CONNECTION USING CODED POLYMAGNETS | |
WO2009074286A3 (en) | Pharmaceutical formulation comprising ezetimibe | |
CN106358347A (zh) | 一种远程舞台灯光控制系统 | |
CN109922248A (zh) | 一种基于人工智能的实时图像识别装置 | |
EP2837268A1 (de) | Beleuchtungssystem und steuereinheit hierfür | |
WO2008117707A1 (ja) | オルメサルタンメドキソミルの粉砕結晶 | |
DE102014202445A1 (de) | Beleuchtungssystem und Verfahren zum Betrieb eines Beleuchtungssystems mit integriertem Sicherheitskonzept | |
CN204440318U (zh) | 一种脑波智能控制系统 | |
EP3976883A4 (en) | ARTIFICIAL GRASS BLOCK FOR TURF PAVERS | |
EP2260680B1 (de) | Beleuchtungsanordnung mit mehreren separaten beleuchtungseinheiten | |
EP3147264A3 (en) | Systems and methods for mechanically combining loose scrap | |
DE102018217151A1 (de) | Beleuchtungssystem und verfahren | |
MX2009003740A (es) | Pth pegilado como moduladores de receptor pth y usos de los mismos. | |
EP2270947A3 (de) | Vorrichtung zur Energieverteilung und Verfahren | |
EP1188726A3 (de) | Zuschlagstoff, insbesondere für Beton, sowie ein Verfahren zu dessen Herstellung | |
WO2006007881A3 (en) | New pharmaceutical compositions based on fluorenecarboxyclic acid esters and soluble tnf receptor fusion proteins |